Qulipta scores 60/100 (At Risk) based on analysis of 30s promotional content. 2 enforcement patterns detected across Visual Distraction — “Outdoor & Physical Activity” identified at 0.0s, previously cited in BRUKINSA, COBENFY, Fasenra (x3). FDA enforcement letter on file dated Sep 9, 2025. Weakest dimension: Content Lifecycle at 17/100.
Matched against 14 enforcement patterns from 42 FDA letters